Prostate cancer is one of the most common cancers among men and people assigned male at birth. In the United States alone, it accounts for a large share of cancer diagnoses and deaths each year pmc.ncbi.nlm.nih.gov and mdpi.com. Historically, prostate cancer in gay, bisexual, and transgender individuals was a “hidden” issue, often overlooked in research and healthcare pmc.ncbi.nlm.nih.gov. Today, we understand that while the disease itself may be the same, LGBTQ+ patients can face unique challenges related to their sexual health, emotional well-being, and healthcare experiences. Recent studies have started to shed light on these differences, revealing disparities in quality of life outcomes and access to care for sexual and gender minorities with prostate cancer pmc.ncbi.nlm.nih.gov. In this post, we’ll explore some of these unique considerations – from sexual side effects and intimacy issues, to stigma in healthcare, differences in screening, survivorship hurdles, mental health, and the importance of LGBTQ-affirming care and support. Our goal is to discuss these topics in an accessible way for a general audience, using the latest peer-reviewed research to inform and educate.

Sexual Side Effects and Intimacy in LGBTQ+ Patients

Prostate cancer treatments (such as surgery or radiation) commonly lead to sexual side effects in all patients, like erectile dysfunction or changes in orgasm. However, gay and bisexual men may experience these side effects differently or more acutely in the context of their sexual practices and relationships pmc.ncbi.nlm.nih.gov. For example, gay men often engage in anal intercourse, and the prostate can play a role in sexual pleasure during receptive sex. A heterosexual man might notice erectile issues or dry orgasms, but a gay man could face additional specific losses that affect intimacy with male partners pmc.ncbi.nlm.nih.gov. Researchers have identified several sexual side effects that are particularly relevant for gay and bisexual prostate cancer survivors:

Loss of prostate stimulation: Removal or damage of the prostate can eliminate it as a source of sexual pleasure. Gay men who were receptive partners in anal sex may lose pleasurable sensations that the prostate used to provide pmc.ncbi.nlm.nih.gov
.
Loss of ejaculate: Many prostate cancer treatments result in little or no semen (dry orgasm). While this occurs for all men, some gay and bisexual men report that the presence of ejaculate was an important aspect of their sexual experience, and its loss can impact their satisfaction pmc.ncbi.nlm.nih.gov
.
Rectal side effects: Radiation therapy can cause irritation or pain in the rectal area. This may interfere with receptive anal intercourse, sometimes making it too painful or difficult for a gay man to continue that aspect of his sex life pmc.ncbi.nlm.nih.gov.
Erectile dysfunction and sexual role: Difficulty achieving erections can affect insertive anal sex pmc.ncbi.nlm.nih.gov. In male couples, if one partner cannot maintain an erection for penetrative sex, they may need to adapt their sexual activities. For some, this may involve exploring different sexual roles or practices, which can be a significant adjustment.

Despite these challenges, studies also show that gay and bisexual men tend to be resourceful in adapting their sex lives after prostate cancer. In fact, some research has found gay and bi men report equal or even better sexual function scores compared to heterosexual men after treatment, potentially because they are often open to redefining intimacy and trying new strategies pmc.ncbi.nlm.nih.gov. For example, male couples might alternate roles (one partner becoming the receptive partner instead of insertive, or vice versa) or incorporate sexual aids and toys to maintain a fulfilling sex life pmc.ncbi.nlm.nih.gov. In a large survey-based study, prostate cancer survivors who identified as gay or bisexual commonly used aids like vacuum pumps, constriction rings, and anal dilators, and many continued practices like masturbation and pelvic floor exercises to accommodate their sexual changes pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. This flexibility and creativity can help preserve intimacy, although it doesn’t negate the fact that sexual side effects remain a significant concern.

It’s worth noting that transgender women (individuals assigned male at birth who identify as women) can also get prostate cancer. A transgender woman who has had gender-affirming surgery usually still has her prostate intact pmc.ncbi.nlm.nih.gov. Sexual side effects for transgender patients may take on a different dimension. For example, a transgender woman on long-term estrogen therapy might already experience reduced erectile function. If she develops prostate cancer, treatments like surgery or radiation could further alter her sexual experience and potentially impact any surgically constructed genitals or tissue in that region pmc.ncbi.nlm.nih.gov. Research on sexual outcomes in transgender prostate cancer patients is extremely limited (mostly isolated case reports), but experts emphasize the need for individualized care plans in these cases pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. In summary, sexual side effects are a major aspect of prostate cancer survivorship for LGBTQ+ individuals, requiring both patients and providers to communicate openly and consider adaptive strategies to maintain intimacy.

Stigma and Discrimination in Healthcare

Many LGBTQ+ prostate cancer patients worry not just about the disease, but also about how they will be treated by healthcare professionals. Stigma and discrimination in medical settings are unfortunate realities that can deeply affect the patient experience. A recent study of gay and bisexual prostate cancer survivors in the U.S. found that nearly half (49%) reported experiencing at least one instance of discrimination during their cancer treatment pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. In about one-third of these cases, patients felt they were treated unfairly specifically because of their sexual orientation pubmed.ncbi.nlm.nih.gov. Examples ranged from hearing insensitive remarks to sensing a provider’s discomfort or bias. Some men even avoided taking their partner to appointments or withheld information about their personal life out of fear of negative reactions.

Stigma in healthcare can take subtle forms as well. Often, medical intake forms and providers default to assumptions of heterosexuality – asking a man about his “wife,” for instance, or not considering that a patient’s support person might be a same-sex partner. This heteronormative bias can make gay and bisexual patients feel invisible or alienated. In a qualitative study, sexual minority men described hesitancy to disclose their orientation or bring their partners to consultations because they weren’t sure how the doctor or staff would react pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. Such concealment, while understandable, can hinder effective care. For instance, if a man doesn’t feel safe telling his urologist that he has sex with men, the doctor might not discuss certain sexual side effects (like those related to anal sex) or might give advice that isn’t relevant to the patient’s life.

The impact of discrimination isn’t just emotional; it’s linked to worse health outcomes. The study mentioned earlier noted that men who experienced any discrimination had significantly poorer health-related quality of life scores during survivorship pubmed.ncbi.nlm.nih.gov. This means that beyond the immediate hurt, stigma can contribute to higher stress, less open communication, and potentially delayed care or reduced adherence to treatment recommendations. Addressing this issue requires effort on multiple fronts. Healthcare providers need training in cultural competence and humility, so they can interact with LGBTQ+ patients without bias and with understanding. Small steps – like using inclusive language, mentioning “partner” instead of assuming a gender, and displaying a nonjudgmental attitude – make a big difference. From the patient side, finding doctors or clinics known to be LGBTQ-friendly can reduce fear of discrimination. Some cancer centers now advertise their commitment to diversity and have non-discrimination policies clearly in place. Ultimately, no patient should have to educate their doctor on respect, but speaking up (when safe to do so) about one’s identity and needs can encourage a better dialogue. The goal is a healthcare environment where gay, bisexual, and transgender prostate cancer patients feel safe, validated, and able to focus on healing rather than hiding – an environment in which who you are and whom you love never compromises the care you receive.

Disparities in Screening and Diagnosis

Early detection of prostate cancer often relies on screening with the prostate-specific antigen (PSA) blood test and follow-up exams. However, there are indications that LGBTQ+ individuals may not be benefiting equally from these early detection efforts. Research on prostate cancer screening in sexual minorities has yielded mixed findings, but it does suggest some disparities in access and practice. For example, a comprehensive review noted that gay and bisexual men appear to be screened for prostate cancer at lower rates than heterosexual men in some populations pmc.ncbi.nlm.nih.gov. There could be several reasons for this. Gay and bi men, especially if they are single or not open about their sexuality, might be less likely to have a regular primary care provider or to discuss sensitive health issues, leading to fewer opportunities to get recommended PSA testing pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. Additionally, historically, public health messages about prostate cancer were often targeted to straight men (through outlets like married men’s groups, etc.), potentially missing segments of the LGBTQ+ community.

On the other hand, some studies suggest an opposite trend in certain contexts. A U.S. survey by Ma and colleagues found that gay and bisexual men who are engaged with healthcare were just as likely – if not more likely – to undergo PSA screening if their doctor recommended pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. In fact, an earlier report hinted that men who do not identify as heterosexual might actually participate in more rigorous prostate cancer screening, possibly due to greater concern about sexual function loss if cancer treatment became necessary pmc.ncbi.nlm.nih.gov. For instance, the idea of losing the ability to ejaculate or have sex after a prostatectomy was cited as a motivation for some gay men to be proactive about screening and early treatment pmc.ncbi.nlm.nih.gov. These seemingly conflicting findings tell us that the LGBTQ+ community is not monolithic – healthcare behaviors can vary widely. Factors like socioeconomic status, education, geographic location, and how connected a person is to LGBTQ-aware healthcare resources likely influence whether they get screened.

Transgender individuals face their own set of challenges. Trans women (who have a prostate but may not identify or be categorized as “men” in healthcare systems) often fall through the cracks of prostate cancer screening programs. Routine screenings that target men by age may miss trans women, especially if their medical providers focus on gender-affirming care and don’t emphasize organ-specific screening. A recent analysis reported that transgender women were significantly less likely than cisgender men to have ever discussed PSA screening with a provider pmc.ncbi.nlm.nih.gov. There is also no consensus guideline on if or when to screen trans women for prostate cancer, partly because the incidence in this group is hard to determine. Long-term estrogen therapy and androgen deprivation (common in trans feminine care) likely lower prostate cancer risk, but they don’t eliminate it pmc.ncbi.nlm.nih.gov. In fact, a review of published case reports found that when prostate cancer does occur in transgender women, it has often been diagnosed at a later, more advanced stage (in one series, more than half the reported cases were metastatic at presentation) pmc.ncbi.nlm.nih.gov. This suggests that many trans women may not be getting exams or PSA tests until symptoms arise.

Overall, disparities in screening and diagnosis can mean that LGBTQ+ patients might be diagnosed at different stages or face delays. To improve early detection, it’s crucial that healthcare providers consider each patient’s situation. For gay and bisexual men, doctors should create a welcoming space to talk about screening, and emphasize that sexual orientation does not change the need for age-appropriate cancer checks. For transgender women, providers should remember that even if a patient is female-presenting, a prostate is present and needs attention if the individual is of screening age or has risk factors pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. Shared decision-making is key: discussions about the pros and cons of PSA testing should be tailored to the person – including their anatomy, hormone use, and preferences. Reducing barriers (like lack of insurance or fear of discrimination) is also important, because access to regular healthcare is a predictor of who gets screened mdpi.com. As awareness grows, the hope is that no one will miss out on early detection simply because of their sexuality or gender identity.

Challenges in Survivorship

Surviving prostate cancer is not just about living through the treatment – it’s about navigating life afterward. Survivorship brings its own challenges, from managing lasting side effects to finding support and meaning after cancer. Gay, bisexual, and transgender survivors often have to confront these issues with additional layers of complexity. One major challenge is finding adequate support. Many straight men rely heavily on their wives or female partners as caregivers during and after prostate cancer treatment. In contrast, gay and bisexual men may have very different support networks. Some have long-term male partners or husbands who take on caregiver roles, but others might be single, or in relationships where traditional caregiving dynamics differ. A qualitative study that interviewed gay and bisexual prostate cancer patients found that these men drew support from a “chosen family” of friends, siblings, ex-partners, and community members pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. While it’s heartening that support can come from many sources, the same study noted that overall support levels were often low – several men felt they had to handle much of the burden themselves, either by choice or because they didn’t want to “bother” their friends pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. In fact, a common theme among single gay men was a strong independence streak: some intentionally turned down offers of help, perhaps due to pride or fear of imposing on others pubmed.ncbi.nlm.nih.go pubmed.ncbi.nlm.nih.gov.

This relative lack of built-in support can make recovery and coping more difficult. Everyday tasks during treatment (like getting to appointments or managing at home after surgery) can be hard without a caregiver. Emotionally, not having someone to confide in daily may increase feelings of isolation. It’s not surprising that research has linked social support to quality of life in prostate cancer survivors. In a survey of 186 gay and bisexual prostate cancer survivors, those who reported lower overall social support had worse cancer-related symptom distress and poorer mental well-being pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. Moreover, men who felt they wanted more support than they were getting tended to report worse prostate cancer-specific quality of life outcomes pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. These findings underline that support isn’t just a “nice to have” – it can directly impact how well someone recovers and thrives after cancer.

Another survivorship challenge is the fit (or lack thereof) of existing support programs. Traditional prostate cancer support groups and educational resources have typically catered to heterosexual men and their wives. As a result, LGBTQ+ survivors often feel out of place. They might hear conversations that don’t resonate – for instance, discussions about regaining sexual function might focus on heterosexual intercourse, or there may be assumptions about the patient’s family structure (like concerns about “being intimate with your wife” or fertility issues related to having children). Gay and bisexual men have expressed a strong desire for support groups specifically for men like them who have lived through prostate cancerpubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. Many have unique questions or experiences they want to share, such as how to disclose their cancer history to new partners in the gay community, or how to deal with changes in sexual roles with a male partner. Fortunately, specialized support resources have been emerging. There are now nonprofit organizations and online communities that host prostate cancer support groups for gay and bisexual men, allowing them to connect with peers who truly understand their journey. These groups create a space where one doesn’t have to explain their identity – they can directly talk about issues at the intersection of cancer and LGBTQ life.

Transgender survivors face yet another set of issues in survivorship. A trans woman who undergoes prostate cancer treatment might wonder: will radiation affect her feminizing surgeries? How does hormone therapy (estrogen) interact with prostate cancer management, and will she be taken off her hormones during treatment? These are challenging questions that many oncologists and urologists haven’t historically had to answer. Because transgender prostate cancer cases have been rare, survivors often have to tread a new path without precedent. The lack of research data means trans survivors and their doctors must problem-solve together, balancing cancer control with maintaining gender affirmation. For example, some trans women may experience distress if they have to stop estrogen (which could happen during certain treatments), and they will need both medical and emotional support through that process pmc.ncbi.nlm.nih.gov. If surgery is needed, considerations like preserving the neovagina (if one is present) and ensuring respectful perioperative care (correct pronouns, etc.) are vital parts of survivorship planning.

In summary, life after prostate cancer can be complex for anyone, but LGBTQ+ individuals often walk this road with fewer established guideposts. Building supportive communities, whether through partners, friends, or organized groups, is crucial. So is increasing awareness among healthcare professionals that gay, bisexual, and transgender survivors have distinct needs. By acknowledging and addressing these survivorship challenges, we can improve long-term outcomes and quality of life for this community of patients.

Mental Health Considerations

Dealing with cancer can take a toll on anyone’s mental health. Anxiety about treatments, fear of recurrence, and changes in one’s body can lead to stress, depression, or a sense of lost identity. For gay, bisexual, and transgender individuals with prostate cancer, these mental health challenges can be amplified by the backdrop of societal pressures and the personal significance of sexual and gender identity. Research suggests that sexual minority men often report worse mental well-being after prostate cancer compared to their heterosexual counterparts pmc.ncbi.nlm.nih.gov. There are a few reasons why this might be the case. One factor is minority stress – the chronic stress that comes from being part of a stigmatized or marginalized group. Over a lifetime, facing discrimination or the need to hide one’s true self can increase the risk of anxiety and depression. When a serious illness like cancer enters the picture, it can compound that burden. Indeed, the stress of cancer plus the stress of stigma can interact in harmful ways. A 2020 study pointed out that gay and bi prostate cancer survivors scored worse on emotional well-being scales, and the authors speculated that the additional pressures of being a sexual minority (such as fear of rejection or lack of family support) likely play a role in this mental health gap pmc.ncbi.nlm.nih.gov.

Another aspect is how prostate cancer treatments affect things tied closely to masculine identity and sexuality. Prostate cancer often forces changes in what it means to “feel like a man” – for example, the loss of erectile function or fertility, changes in muscle mass during hormone therapy, etc. Gay men may experience this loss of virility as a double hit: it challenges their identity as men, and it affects their identity as sexual beings within the gay community. One study explored masculine self-esteem in gay men after prostate cancer, finding that many men experienced a blow to their sense of manhood following treatment pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. Interestingly, that research found gay men who were comfortable being out to their healthcare providers and who did not perceive a lot of stigma tended to maintain better self-esteem and mental health pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov. In contrast, those who felt the need to hide their sexuality or who encountered stigma had more trouble with self-image and had higher levels of regret and distress. What this tells us is that affirmation and acceptance can be protective: when gay men feel supported for who they are, they cope better with the impacts of cancer on their masculinity and mental state pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Depression and anxiety are not uncommon after prostate cancer, regardless of orientation. However, LGBTQ+ patients might face specific triggers for these conditions. For example, a gay man who loses his ability to have penetrative sex might worry about finding or keeping a partner, leading to loneliness or despair. A bisexual man who has not disclosed his sexuality widely might feel he has “nowhere to turn” to discuss his fears openly. A transgender woman might experience gender dysphoria if treatment side effects (like stopping hormones or experiencing body changes) make her feel less in line with her gender identity. It is crucial that mental health support is integrated into cancer care for these individuals. Professional counseling or therapy can provide a safe space to work through feelings of grief, anger, or anxiety related to changes in sexual function and identity. Support groups – especially those tailored to LGBTQ+ cancer survivors – can also alleviate isolation by connecting patients with others who have similar experiences.

There’s also an element of resilience that deserves mention. Many LGBTQ+ people have already developed coping skills from navigating life in a sometimes unaccepting world. These same skills can help in facing cancer. Resilience might manifest as finding new ways to define intimacy and relationship satisfaction beyond the physical changes, or an enhanced ability to adapt to a “new normal.” One study from the Restore research project noted that gay and bisexual men often reframed their approach to sexuality post-treatment, focusing on what they could still do and enjoy, rather than what they lost pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov. This kind of positive coping is beneficial for mental health. Still, resilience is not infinite, and it doesn’t mean LGBTQ+ survivors don’t need support – they absolutely do. In fact, mental health professionals knowledgeable about both oncology and LGBTQ+ issues can be invaluable. These professionals understand the significance of things like chosen family, internalized homophobia, or gender dysphoria, and can help patients navigate complex emotions in a culturally sensitive way. Overall, attention to mental health is a key part of treating the “whole patient.” By acknowledging the unique mental and emotional challenges that gay, bi, and trans survivors may face, we can better support them in living full, satisfying lives after cancer.

Access to LGBTQ-Affirming Care and Support

Given all the considerations discussed, one thing becomes clear: access to competent, LGBTQ-affirming healthcare and support services is essential. Unfortunately, not everyone has equal access. Historically, sexual and gender minorities have been medically underserved. For instance, studies have shown that LGBTQ+ individuals are less likely to have health insurance or a regular healthcare provider, and more likely to delay seeking care due to fear of discrimination mdpi.com mdpi.com. This can create a dangerous gap in preventive care, cancer screening, and even timely treatment. When prostate cancer is on the line, delays in diagnosis or treatment can affect outcomes. Therefore, bridging the access gap is a matter of urgency.

On the healthcare provider side, LGBTQ-affirming care means more than just not discriminating. It means actively creating an environment where patients feel seen and respected. This includes using inclusive language (e.g., asking about “partners” instead of assuming gender), having non-discrimination statements visible, and training staff on LGBTQ+ cultural competency mdpi.com. Culturally competent providers are aware of unique health needs – for example, they know that a transgender woman still needs prostate care, or that a gay man might benefit from pelvic floor physical therapy tailored to his sexual practices. When providers are knowledgeable and open, patients are more likely to disclose relevant information and participate in their care without fear. Medical schools and professional groups are increasingly offering training modules on LGBTQ+ health, and some cancer centers have specialized clinics or patient navigators for sexual and gender minority patients. If you are a patient, it’s okay to seek out a second opinion or a different doctor if you feel your current provider doesn’t “get” your needs. Many large cities have referral services or directories for LGBTQ-friendly healthcare professionals.

Support services are the other half of the equation. Beyond the medical treatment of prostate cancer, patients often need guidance, community, and practical help. Organizations such as Malecare (a nonprofit focused on men’s cancer support, which notably has programs for gay and bisexual men) have been pioneers in providing tailored support. There are also online forums, and local support groups (sometimes hosted by community centers or advocacy groups) specifically for LGBTQ+ cancer survivors. Accessing these can significantly improve a patient’s experience. In these spaces, individuals can talk freely about issues like dating after prostate cancer in the gay community, dealing with changes in sexual orientation identity post-surgery, or how hormone therapy side effects intersect with HIV medication, for example. The value of peer support – hearing “I went through this too, and here’s how I coped” – cannot be overstated. It reduces the feeling that one is alone in this journey.

For transgender individuals, finding affirming care may require a bit more effort simply because there are fewer of them in the prostate cancer survivor pool, and not all support groups or resources will automatically include transgender-specific discussions. However, some general cancer organizations are now creating materials for trans cancer patients, and a few case reports and reviews offer guidance on managing prostate cancer in trans women pmc.ncbi.nlm.nih.gov. If you are a trans woman with prostate cancer, you may benefit from consulting both an oncologist and an endocrinologist who are experienced with transgender healthcare to collaborate on your treatment plan. It’s also completely reasonable to ask any support group or counselor if they have worked with transgender clients before – you deserve care providers who will respect your gender identity throughout.

In practical terms, here are a few tips for improving access and support:

Find “your” doctor: If possible, choose healthcare providers who have experience with LGBTQ+ patients or who explicitly advertise inclusivity. These providers are more likely to be aware of unique concerns and to make you comfortable.
Leverage support organizations: Groups like the LGBTQ Cancer network or specific prostate cancer survivor groups for gay and bi men can connect you to resources. They might offer mentor programs, where a newly diagnosed patient is paired with an LGBTQ+ survivor who has been through it, providing one-on-one support.
Bring a support person to appointments: Whether it’s your partner, a close friend, or an advocate, having someone with you can ensure your concerns are voiced. This person can also help take notes and provide emotional backing if you need to discuss sensitive topics with your doctor.
Educate when you can (and when you want to): It is not your job to train your doctor in LGBTQ+ issues – but if you feel up to it, letting your healthcare team know what could improve your comfort is helpful. Sometimes a simple statement like, “My partner is a man, and I’d like him involved in discussions,” or “As a gay man, I have specific questions about how this treatment will affect my sex life,” can prompt your provider to address things they might not have otherwise. Good providers will welcome this information and adjust accordingly.
Use mental health and social work services: Many cancer centers have social workers or patient navigators. Ask if any on staff have expertise in working with LGBTQ+ patients. They can help coordinate care and link you to financial resources or counseling. In some cases, they can even advocate on your behalf if you encounter bias.

Access to affirming care is about ensuring every patient – regardless of sexual orientation or gender identity – gets high-quality, respectful, and relevant care. The prostate cancer journey is challenging enough without the added worry of “Will my doctor judge me?” or “No one understands what I’m going through.” With continued advocacy, education, and the growth of tailored services, the medical community is gradually becoming more equipped to meet these needs. And as more LGBTQ+ prostate cancer survivors share their stories, they pave the way for others to get the care and support they deserve.

Conclusion
Prostate cancer does not discriminate – it affects gay, bisexual, transgender, and straight individuals alike. Yet, as we’ve discussed, the experience of prostate cancer can differ significantly for those in the LGBTQ+ community. From unique sexual side effects (like changes in how one can give or receive intimacy) to challenges with stigma in healthcare settings, from differences in screening participation to the nuances of post-treatment life and mental health, these perspectives matter. They matter because recognizing them is the first step toward providing better care and support. Over the last decade, researchers and clinicians have begun to illuminate these issues. We now know, for example, that nearly half of gay and bisexual men may face discrimination during treatment pubmed.ncbi.nlm.nih.gov, that targeted rehabilitation programs need to focus on helping patients adapt rather than expecting a full return to pre-cancer sexual function pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov, and that strong social support can significantly improve quality of life for sexual minority survivors pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov.

For LGBTQ+ individuals facing prostate cancer, perhaps the most important message is this: You are not alone, and your concerns are valid. There are experts, resources, and communities out there dedicated to addressing exactly what you’re going through. It’s okay to seek out a second opinion or a specialist who understands your identity. It’s okay to ask for a support group that reflects your life experience. And it’s absolutely okay to prioritize your mental health through all of this. Likewise, for healthcare providers and loved ones of LGBTQ+ patients, the key takeaway is to listen and learn. Avoid assumptions, ask open-ended questions, and educate yourself on the unique needs discussed here. A prostate cancer diagnosis is tough, but with empathy, knowledge, and inclusivity, we can ensure that everyone – gay, straight, cisgender, transgender, or otherwise – has the best possible chance at not only surviving, but thriving after prostate cancer.

References

Yazdanpanah O, Benjamin DJ, Kalebasty AR. Prostate Cancer in Sexual Minorities: Epidemiology, Screening and Diagnosis, Treatment, and Quality of Life. Cancers (Basel). 2023;15(9):2654.
Bates AJ, Ross MW, Rosser BRS, Wheldon CW,Mitteldorf D, Polter EJ, Talley KMC, et al. Discrimination against Gay and Bisexual Patients in Prostate Cancer Treatment: Results from the Restore-2 Study. Stigma Health. 2024;9(4):506-517.
Rosser BRS, Polter EJ, Talley KMC, Wheldon CW, Mitteldorf D,Haggart R, Wright MM, et al. Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results from the Restore-2 Study. Front Oncol.2022;12:812117.
Rosser BRS, Kohli N, Bates AJ, Mitteldorf D, Talley KMC, Wright MM, Polter EJ, et al. Does sexual rehabilitation work for gay and bisexual prostate cancer patients? Acceptability, feasibility, and efficacy results from the Restore-2 randomized controlled trial. J Cancer Surviv. 2024 (Sep 12) [Online ahead of print].
Rosser BRS, Mitteldorf D, West W, DeWitt J, Kilian G. The Sexual Functioning of Gay and Bisexual Men Following Prostate Cancer Treatment: Results from the Restore Study. Arch Sex Behav. 2020;49(5):1589-1600.
Capistrant BD, Torres B, Merengwa EN, West WG, Mitteldorf D, Rosser BRS. Caregiving and social support for gay and bisexual men with prostate cancer. Psychooncology. 2016;25(11):1329-1336.
Capistrant BD, Merengwa E, Mitteldorf D, Kohli N, et al. Social Support and Health-Related Quality of Life Among Gay and Bisexual Men With Prostate Cancer. Oncol Nurs Forum. 2018;45(4):439-455.
Allensworth-Davies D, Talcott JA, Heeren T, de Vries B, Blank TO, Clark JA, et al. The health effects of masculine self-esteem following treatment for localized prostate cancer among gay men. LGBT Health. 2016;3(1):49-56.
Crowley F, Mihalopoulos M, Gaglani S, Tewari AK, Tsao CK, Djordjevic M, et al. Prostate cancer in transgender women: considerations for screening, diagnosis and management. Nat Rev Urol. 2023;20(4):206-220. (PMID: 36261584)